Related Experiment Video
Updated: May 18, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Drug-induced thrombocytopenia: a less known interaction
Manjari Pandey1, Lavanya Yarlagadda
1Johns Hopkins University/Sinai Hospital of Baltimore, Baltimore, Maryland 21215, USA. pandey.manjari@gmail.com
A 57-year-old woman with a left frontal lobe tumor was started on seizure prophylaxis with phenytoin and dexamethasone while awaiting elective surgery for tumor excision. Within a week, she developed a rash all over her body secondary to phenytoin hypersensitivity and her platelet counts decreased progressively to as low as 20,000/μl. Phenytoin was discontinued and she was given intravenous immunoglobulin for 2 days. She had progressive recovery of the platelet count to her baseline over the next 6 days. This case of phenytoin-induced thrombocytopenia emphasizes the importance of recognizing thrombocytopenia secondary to drug use and also highlights a lesser known but important interaction between phenytoin and dexamethasone to enhance this effect. We also provide a brief review of the literature and comment on the pathophysiology of this rare condition.
A 57-year-old woman with a left frontal lobe tumor was started on seizure prophylaxis with phenytoin and dexamethasone while awaiting elective surgery for tumor excision. Within a week, she developed a rash all over her body secondary to phenytoin hypersensitivity and her platelet counts decreased progressively to as low as 20,000/μl. Phenytoin was discontinued and she was given intravenous immunoglobulin for 2 days. She had progressive recovery of the platelet count to her baseline over the next 6 days. This case of phenytoin-induced thrombocytopenia emphasizes the importance of recognizing thrombocytopenia secondary to drug use and also highlights a lesser known but important interaction between phenytoin and dexamethasone to enhance this effect. We also provide a brief review of the literature and comment on the pathophysiology of this rare condition.
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Drug toxicity: Idiosyncratic Reactions
